These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38313974)
1. Adult-Onset Still's Disease After an mRNA COVID-19 Vaccine in an Older Woman. Nishioka H; Shirota S Cureus; 2024 Jan; 16(1):e51540. PubMed ID: 38313974 [TBL] [Abstract][Full Text] [Related]
2. Flare of adult-onset Still's disease following mRNA COVID-19 vaccination: a case report and review of literature. Kim JW; Jung JY; Suh CH; Kim HA Clin Rheumatol; 2022 May; 41(5):1583-1589. PubMed ID: 35182269 [TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in a patient with adult-onset Still's disease following first COVID-19 vaccination with BNT162b2. Muench F; Krusche M; Sander LE; Rose T; Burmester GR; Schneider U BMC Rheumatol; 2021 Dec; 5(1):60. PubMed ID: 34961551 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still's Disease. Hugues B; Ben Amer H; Bril F; Groh M; Huang F Eur J Case Rep Intern Med; 2022; 9(8):003469. PubMed ID: 36093302 [TBL] [Abstract][Full Text] [Related]
6. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences. Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q Front Immunol; 2020; 11():603389. PubMed ID: 33552062 [TBL] [Abstract][Full Text] [Related]
7. Adult-onset Still's Disease after BNT162b2 mRNA COVID-19 Vaccine. Park SY; Lee KH J Korean Med Sci; 2021 Dec; 36(50):e344. PubMed ID: 34962116 [TBL] [Abstract][Full Text] [Related]
8. First report of a patient meeting criteria for both multisystem inflammatory syndrome in children and adult onset Still's disease. Alexandri M; Patel J; Paul E; Coule LW BMC Rheumatol; 2022 Dec; 6(1):87. PubMed ID: 36575537 [TBL] [Abstract][Full Text] [Related]
9. Occurrence of adult-onset Still's disease after coronavirus disease 2019 BNT162B2 vaccination in a patient with ulcerative colitis: A case report and review of literature. Kobayashi T; Hashimoto K; Kusanagi Y; Tanaka Y Clin Case Rep; 2023 Dec; 11(12):e8298. PubMed ID: 38076011 [TBL] [Abstract][Full Text] [Related]
10. Adult-Onset Still's Disease following Coronavirus 2 (SARS-CoV-2) Vaccination: A Case Report. Chua XH; Lin WL; Lee YT Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298552 [TBL] [Abstract][Full Text] [Related]
11. New-onset Adult-onset Still's Disease Following COVID-19 Vaccination: Three Case Reports and a Literature Review. Matsuda M; Funakubo Asanuma Y; Yokota K; Sakai S; Yazawa H; Maruyama T; Tsuzuki Wada T; Araki Y; Mimura T Intern Med; 2023 Jan; 62(2):299-305. PubMed ID: 36351580 [TBL] [Abstract][Full Text] [Related]
12. Adult-Onset Still's Disease After the ChAdOx1 nCoV-19 Vaccine. AlQudari EA; Alabdan LI; Alkhathami AA; Alotaibi MD; Alhamzi HA Cureus; 2022 Jan; 14(1):e21279. PubMed ID: 35186544 [TBL] [Abstract][Full Text] [Related]
13. Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus. Hirooka Y; Okuda S; Sugiyama M; Shiga T; Nozaki Y; Kinoshita K; Funauchi M; Matsumura I Front Immunol; 2022; 13():822169. PubMed ID: 35116046 [TBL] [Abstract][Full Text] [Related]
14. Adult-Onset Still's Disease Following COVID-19 Infection in a Patient Receiving Nirmatrelvir/Ritonavir: A Case Report. El Hasbani G; Applewhite AI; Scheuing W; Maher L Cureus; 2024 May; 16(5):e60946. PubMed ID: 38910713 [TBL] [Abstract][Full Text] [Related]
15. Case report: Coronavirus Disease 2019 (COVID-19) modified RNA vaccination-induced Adult-Onset Still's Disease with fulminant myocarditis as initial presentation. Zhou M; Wong CK; Yeung WYW; Siu CW; Yin L Front Cardiovasc Med; 2023; 10():1066699. PubMed ID: 37008321 [TBL] [Abstract][Full Text] [Related]
16. Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still's disease. Hong X; Pan H; Su Y; Hu Q; Sun Y; Liu H; Cheng X; Ye J; Shi H; Meng J; Zhou Z; Jia J; Liu T; Wang M; Chen X; Ma Y; Tang Z; Wang F; Zhang H; You Y; Zhu D; Chen L; Yang C; Teng J; Chi H Rheumatology (Oxford); 2023 Jun; 62(6):2262-2266. PubMed ID: 36282541 [TBL] [Abstract][Full Text] [Related]
17. Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease. Hiyama T; Kurasawa K; Hasegawa A; Miyao T; Tanaka A; Arai S; Arima M; Maezawa R Clin Exp Med; 2023 Nov; 23(7):3407-3416. PubMed ID: 36611087 [TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease]. Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776 [TBL] [Abstract][Full Text] [Related]
19. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Maria AT; Le Quellec A; Jorgensen C; Touitou I; Rivière S; Guilpain P Autoimmun Rev; 2014 Nov; 13(11):1149-59. PubMed ID: 25183244 [TBL] [Abstract][Full Text] [Related]
20. A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient. Jeon YH; Lim DH; Choi SW; Choi SJ Rheumatol Int; 2022 Apr; 42(4):743-748. PubMed ID: 34797392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]